Data for Biomarkers for different types of Multiple Scelerosis (MS) (BMS vs SPMS lipidomics) (Study ST000688)

(Analysis AN001061)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2
CerP 32:1; [M-H]-@5.19 1.0698 0.9547
CerP 34:0; [M-H]-@6.17 1.1016 0.9339
CerP 34:1; [M-H]-@5.94 1.0044 0.9971
CerP 34:2; [M-H]-@5.40 1.0960 0.9376
CerP 38:1; [M-H]-@7.29 1.0952 0.9381
CerP 41:1; [M-H]-@8.14 0.9846 1.0100
CerP 42:1; [M-H]-@8.41 1.0370 0.9759
CL 66:1; [M-2H](2-)@6.26 1.0859 0.9442
CL 74:3; [M-2H](2-)@6.99 1.2098 0.8637
CL 76:5; [M-2H](2-)@6.98 1.1603 0.8958
CL 78:5; [M-2H](2-)@6.51 1.0554 0.9640
FFA(16:0) 0.8681 1.0857
FFA(18:0) 0.8963 1.0674
FFA(18:1) 0.7499 1.1626
FFA(18:2) 0.7436 1.1667
FFA(20:0) 0.6487 1.2283
FFA(20:1) 0.7337 1.1731
FFA(20:2) 0.7144 1.1856
FFA(20:4) Arachidonic acid 0.7115 1.1876
FFA(22:0) 0.7437 1.1666
FFA(22:1) 0.9561 1.0286
FFA(22:2) 0.9254 1.0485
FFA(22:3) 0.8299 1.1106
FFA(24:0) 1.2216 0.8559
FFA(24:1) 0.8455 1.1004
FFA(24:2) 0.7392 1.1695
FFA(24:3) 0.7938 1.1340
lysoPE 16:0; [M-H]-@1.66 0.9529 1.0306
lysoPE 17:0; [M-H]-@2.08 1.0729 0.9526
lysoPE 18:1; [M-H]-@1.80 0.9124 1.0569
lysoPE 20:1; [M-H]-@2.67 0.9201 1.0520
lysoPE 20:2; [M-H]-@2.09 0.8518 1.0963
lysoPE 20:3; [M-H]-@1.66 1.0521 0.9661
lysoPE 22:4; [M-H]-@1.90 0.9325 1.0439
lysoPE 22:5; [M-H]-@1.56 0.8510 1.0969
lysoPE 22:6; [M-H]-@1.32 0.7988 1.1308
N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.45 1.0027 0.9982
N-(docosanoyl)-sphing-4-enine; [M-H]-@8.43 1.1442 0.9063
N-(eicosanoyl)-sphing-4-enine; [M-H]-@7.95 1.0153 0.9901
N-(hexadecanoyl)-sphing-4-enine; [M-H]-@6.87 1.0246 0.9840
N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.46 1.0018 0.9988
N-(octadecanoyl)-sphinganine; [M-H]-@7.64 0.8392 1.1045
N-(tetracosanoyl)-sphing-4-enine; [M-H]-@8.88 1.0984 0.9360
PA 34:1; [M-H]-@6.82 0.9838 1.0105
PA 34:2; [M-H]-@6.28 1.0897 0.9417
PA 34:3; [M-H]-@5.77 1.1278 0.9169
PA 36:1; [M-H]-@7.51 1.0063 0.9959
PA 36:3; [M-H]-@6.43 1.1353 0.9120
PA 36:4; [M-H]-@6.20 1.0359 0.9767
PA 36:5; [M-H]-@5.97 1.0059 0.9962
PA 38:5; [M-H]-@6.05 0.9565 1.0283
PA 38:6; [M-H]-@6.21 1.0057 0.9963
PA 40:7; [M-H]-@6.23 1.0299 0.9806
PC 26:0; [M-Ac-H]-@4.57 1.3719 0.7582
PC 30:0; [M-Ac-H]-@6.04 1.0966 0.9372
PC 31:0; [M-Ac-H]-@6.31 1.1013 0.9341
PC 32:0; [M-Ac-H]-@6.75 1.0023 0.9985
PC 32:1; [M-Ac-H]-@6.12 1.0082 0.9947
PC 32:2; [M-Ac-H]-@5.73 1.2703 0.8243
PC 33:1; [M-Ac-H]-@6.56 1.0319 0.9793
PC 33:2; [M-Ac-H]-@6.08 1.0824 0.9464
PC 34:1; [M-Ac-H]-@6.81 0.9772 1.0148
PC 34:2; [M-Ac-H]-@6.30 1.1161 0.9245
PC 34:3; [M-Ac-H]-@5.95 1.0796 0.9483
PC 35:1; [M-Ac-H]-@7.13 0.9444 1.0361
PC 35:2; [M-Ac-H]-@6.66 1.1264 0.9178
PC 35:4; [M-Ac-H]-@6.08 0.9868 1.0086
PC 36:1; [M-Ac-H]-@7.48 1.0114 0.9926
PC 36:2; [M-Ac-H]-@6.98 1.1187 0.9229
PC 36:3; [M-Ac-H]-@6.52 1.1093 0.9290
PC 36:5; [M-Ac-H]-@5.83 1.1164 0.9243
PC 36:6; [M-Ac-H]-@5.54 1.0755 0.9509
PC 37:2; [M-Ac-H]-@7.34 1.1283 0.9166
PC 37:4; [M-Ac-H]-@6.62 1.0531 0.9655
PC 37:6; [M-Ac-H]-@5.86 0.9632 1.0239
PC 38:2; [M-Ac-H]-@7.63 1.0951 0.9382
PC 38:3; [M-Ac-H]-@7.25 1.0614 0.9601
PC 38:5; [M-Ac-H]-@6.50 0.9840 1.0104
PC 38:6; [M-Ac-H]-@6.14 0.9566 1.0282
PC 38:7; [M-Ac-H]-@5.60 1.0347 0.9775
PC 39:6; [M-Ac-H]-@6.54 1.0114 0.9926
PC 40:3; [M-Ac-H]-@7.82 1.0943 0.9387
PC 40:4; [M-Ac-H]-@7.47 0.8950 1.0682
PC 40:5; [M-Ac-H]-@7.11 0.9189 1.0527
PC 40:6; [M-Ac-H]-@6.77 0.9775 1.0146
PC 42:10; [M-Ac-H]-@5.83 0.8455 1.1004
PE 30:0; [M-H]-@5.40 1.2785 0.8190
PE 32:0; [M-H]-@6.78 0.8476 1.0991
PE 32:1; [M-H]-@6.27 1.0613 0.9602
PE 33:0; [M-H]-@7.05 1.1264 0.9178
PE 33:2; [M-H]-@6.11 1.2948 0.8084
PE 34:1; [M-H]-@6.90 0.9486 1.0334
PE 34:2; [M-H]-@6.46 1.1391 0.9096
PE 34:3; [M-H]-@6.00 1.0642 0.9582
PE 34:4; [M-H]-@5.75 1.1031 0.9330
PE 35:0; [M-H]-@7.63 1.0523 0.9660
PE 35:1; [M-H]-@6.55 1.0784 0.9491
PE 35:2; [M-H]-@6.73 1.1573 0.8977
PE 35:4; [M-H]-@6.09 1.0742 0.9517
PE 36:0; [M-H]-@7.90 1.0034 0.9978
PE 36:1; [M-H]-@7.48 1.0129 0.9916
PE 36:2; [M-H]-@7.06 1.2318 0.8493
PE 36:3; [M-H]-@6.58 1.1530 0.9006
PE 36:5; [M-H]-@5.96 1.1356 0.9119
PE 37:4; [M-H]-@6.66 1.0784 0.9490
PE 38:1; [M-H]-@7.49 0.9835 1.0107
PE 38:2; [M-H]-@6.94 1.1504 0.9022
PE 38:3; [M-H]-@7.26 1.1072 0.9304
PE 38:4; [M-H]-@7.03 0.9762 1.0155
PE 38:5; [M-H]-@6.54 0.9991 1.0006
PE 38:7; [M-H]-@5.75 1.1155 0.9249
PE 40:2; [M-H]-@7.64 1.1876 0.8781
PE 40:4; [M-H]-@7.46 0.8129 1.1216
PE 40:6; [M-H]-@6.95 1.0449 0.9708
PE 40:7; [M-H]-@6.43 0.9848 1.0099
PE 40:8; [M-H]-@5.97 0.7764 1.1453
PG 33:0; [M-H]-@6.07 1.1188 0.9228
PG 34:1; [M-H]-@5.83 1.1252 0.9186
PG 34:2; [M-H]-@5.45 1.1187 0.9229
PG 35:0; [M-H]-@6.62 1.0497 0.9677
PG 36:0; [M-H]-@6.89 1.0471 0.9694
PG 36:1; [M-H]-@6.44 1.0583 0.9621
PG 36:2; [M-H]-@6.02 1.1679 0.8909
PG 36:3; [M-H]-@5.31 1.0595 0.9614
PG 38:4; [M-H]-@6.05 0.9522 1.0311
PI 34:1; [M-H]-@5.68 0.9771 1.0149
PI 34:2; [M-H]-@5.22 1.0852 0.9446
PI 35:1; [M-H]-@5.94 1.0768 0.9501
PI 35:2; [M-H]-@5.58 1.0461 0.9700
PI 36:1; [M-H]-@6.31 0.9925 1.0049
PI 36:2; [M-H]-@5.88 1.0784 0.9490
PI 36:3; [M-H]-@5.38 1.1029 0.9331
PI 36:4; [M-H]-@5.22 0.9620 1.0247
PI 38:3; [M-H]-@6.07 1.1426 0.9073
PI 38:4; [M-H]-@5.84 0.9526 1.0308
PI 38:5; [M-H]-@5.37 0.9902 1.0063
PI 38:6; [M-H]-@5.13 1.0053 0.9966
PI 40:4; [M-H]-@6.34 1.0007 0.9995
PI 40:5; [M-H]-@5.99 0.8858 1.0742
PI 40:6; [M-H]-@5.80 0.9621 1.0247
plasmenyl-PE 32:0; [M-H]-@7.15 1.1811 0.8823
plasmenyl-PE 32:1; [M-H]-@6.61 0.8723 1.0830
plasmenyl-PE 34:0; [M-H]-@7.24 1.0424 0.9724
plasmenyl-PE 34:2; [M-H]-@6.75 1.1717 0.8884
plasmenyl-PE 34:3; [M-H]-@6.41 1.0325 0.9789
plasmenyl-PE 36:0; [M-H]-@7.27 0.9437 1.0366
plasmenyl-PE 36:1; [M-H]-@7.78 1.0635 0.9587
plasmenyl-PE 36:2; [M-H]-@7.35 1.0974 0.9367
plasmenyl-PE 36:3; [M-H]-@6.93 1.0384 0.9750
plasmenyl-PE 36:5; [M-H]-@6.30 1.0993 0.9355
plasmenyl-PE 38:1; [M-H]-@8.29 1.0509 0.9669
plasmenyl-PE 38:2; [M-H]-@7.94 1.1056 0.9314
plasmenyl-PE 38:3; [M-H]-@7.56 0.9064 1.0608
plasmenyl-PE 38:4; [M-H]-@7.26 0.7457 1.1653
plasmenyl-PE 40:2; [M-H]-@8.31 0.9696 1.0198
plasmenyl-PE 40:3; [M-H]-@8.07 0.8515 1.0965
plasmenyl-PE 40:5; [M-H]-@7.59 0.8385 1.1050
plasmenyl-PE 40:6; [M-H]-@7.23 0.8693 1.0849
plasmenyl-PE 42:4; [M-H]-@8.25 0.6640 1.2184
plasmenyl-PE 42:5; [M-H]-@7.91 0.7868 1.1386
plasmenyl-PE 42:6; [M-H]-@7.79 0.8859 1.0741
PS 38:4; [M-H]-@6.05 0.2794 1.4684
PS 40:6; [M-H]-@5.88 0.5627 1.2842
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Type of MS:Benign MS
F2Type of MS:SPMS
  logo